ATE455792T1 - Neues phosphatbindendes protein, pharmazeutische zusammensetzungen, die dieses enthalten, und verwendung davon - Google Patents
Neues phosphatbindendes protein, pharmazeutische zusammensetzungen, die dieses enthalten, und verwendung davonInfo
- Publication number
- ATE455792T1 ATE455792T1 AT04805350T AT04805350T ATE455792T1 AT E455792 T1 ATE455792 T1 AT E455792T1 AT 04805350 T AT04805350 T AT 04805350T AT 04805350 T AT04805350 T AT 04805350T AT E455792 T1 ATE455792 T1 AT E455792T1
- Authority
- AT
- Austria
- Prior art keywords
- sequence
- pharmaceutical compositions
- binding protein
- compositions containing
- containing same
- Prior art date
Links
- 102000006335 Phosphate-Binding Proteins Human genes 0.000 title 1
- 108010058514 Phosphate-Binding Proteins Proteins 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 229910019142 PO4 Inorganic materials 0.000 abstract 3
- 239000012634 fragment Substances 0.000 abstract 3
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 abstract 3
- 239000010452 phosphate Substances 0.000 abstract 3
- 150000001413 amino acids Chemical class 0.000 abstract 2
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
- 238000006467 substitution reaction Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/02—Antidotes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2299/00—Coordinates from 3D structures of peptides, e.g. proteins or enzymes
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Toxicology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Immunology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Diabetes (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
- Enzymes And Modification Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0312729A FR2861731B1 (fr) | 2003-10-30 | 2003-10-30 | Nouvelle proteine de fixation du phosphate, compositions pharmaceutiques la contenant et ses utilisations |
| PCT/FR2004/002797 WO2005042572A1 (fr) | 2003-10-30 | 2004-10-29 | Nouvelle proteine de fixation du phosphate, compositions pharmaceutiques la contenant et ses utilisations |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE455792T1 true ATE455792T1 (de) | 2010-02-15 |
Family
ID=34429758
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT04805350T ATE455792T1 (de) | 2003-10-30 | 2004-10-29 | Neues phosphatbindendes protein, pharmazeutische zusammensetzungen, die dieses enthalten, und verwendung davon |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US7718773B2 (de) |
| EP (1) | EP1678204B1 (de) |
| JP (1) | JP4728246B2 (de) |
| CN (1) | CN1898261B (de) |
| AT (1) | ATE455792T1 (de) |
| CA (1) | CA2543935C (de) |
| DE (1) | DE602004025265D1 (de) |
| ES (1) | ES2341174T3 (de) |
| FR (1) | FR2861731B1 (de) |
| IL (1) | IL175319A (de) |
| WO (1) | WO2005042572A1 (de) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| UA95602C2 (ru) | 2004-12-30 | 2011-08-25 | Берингер Ингельхейм Ветмедика, Инк. | Иммуногенная композиция цвс2 и способы приготовления такой композиции |
| US7700285B1 (en) | 2005-12-29 | 2010-04-20 | Boehringer Ingelheim Vetmedica, Inc. | PCV2 immunogenic compositions and methods of producing such compositions |
| US7833707B2 (en) | 2004-12-30 | 2010-11-16 | Boehringer Ingelheim Vetmedica, Inc. | Methods of overexpression and recovery of porcine circovirus type 2 ORF2 |
| US20080226669A1 (en) | 2005-12-29 | 2008-09-18 | Boehringer Ingelheim Vetmedica, Inc. | Multivalent pcv2 immunogenic compositions and methods of producing such compositions |
| PL2371383T3 (pl) | 2005-12-29 | 2016-01-29 | Boehringer Ingelheim Vetmedica Inc | Zastosowanie kompozycji immunogennej do zmniejszania objawów klinicznych u świń |
| WO2008064299A2 (en) * | 2006-11-22 | 2008-05-29 | Boehringer Ingelheim Vetmedica, Inc. | Methods of reducing porcine circovirus-associated disease outbreaks |
| WO2008073464A2 (en) | 2006-12-11 | 2008-06-19 | Boehringer Ingelheim Vetmedica, Inc. | Effective method of treatment of porcine circovirus and lawsonia intracellularis infections |
| ES2625460T5 (es) * | 2006-12-15 | 2020-11-04 | Boehringer Ingelheim Animal Health Usa Inc | Tratamiento de cerdos seropositivos en anticuerpo anti-PCV2 con antígeno de PCV2 |
| EP1941903A1 (de) | 2007-01-03 | 2008-07-09 | Boehringer Ingelheim Vetmedica Gmbh | Prophylaxe und Behandlung von PRDC |
| EP1958644A1 (de) | 2007-02-13 | 2008-08-20 | Boehringer Ingelheim Vetmedica Gmbh | Vorbeugung und Behandlung von subklinischer PCVD |
| US7829274B2 (en) * | 2007-09-04 | 2010-11-09 | Boehringer Ingelheim Vetmedica, Inc. | Reduction of concomitant infections in pigs by the use of PCV2 antigen |
| BRPI0821456A2 (pt) * | 2007-12-31 | 2015-06-16 | Boehring Ingelheim Vetmedica Inc | Partícula similar à pcv2 orf2 com inserção de aminoácido estranho |
| EP2242511A4 (de) | 2008-01-23 | 2012-10-24 | Boehringer Ingelheim Vetmed | Immunogene pcv2-zusammensetzungen gegen mycoplasma hyopneumoniae und verfahren zur herstellung solcher zusammensetzungen |
| FR2942717B1 (fr) * | 2009-03-04 | 2011-08-12 | Centre Nat Rech Scient | Nouvel agent antiviral |
| TWI627281B (zh) | 2009-09-02 | 2018-06-21 | 百靈佳殷格翰家畜藥品公司 | 降低ｐｃｖ－２組合物殺病毒活性之方法及具有改良免疫原性之ｐｃｖ－２組合物 |
| WO2014014918A2 (en) * | 2012-07-16 | 2014-01-23 | St. Luke's-Roosevelt Hospital Center | X-ding-cd4 peptide |
| DK3052516T3 (da) | 2013-10-02 | 2020-03-23 | Boehringer Ingelheim Animal Health Usa Inc | PCV2-ORF2-proteinvariant og viruslignende partikler sammensat deraf |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU4127799A (en) * | 1998-06-12 | 2000-01-05 | University Of Guelph | Pattern recognition proteins |
| US20030158115A1 (en) * | 2000-03-28 | 2003-08-21 | Toback F. Gary | Methods and compositions for detecting and treating kidney diseases associated with adhesion of crystals to kidney cells |
-
2003
- 2003-10-30 FR FR0312729A patent/FR2861731B1/fr not_active Expired - Fee Related
-
2004
- 2004-10-29 AT AT04805350T patent/ATE455792T1/de not_active IP Right Cessation
- 2004-10-29 WO PCT/FR2004/002797 patent/WO2005042572A1/fr not_active Ceased
- 2004-10-29 ES ES04805350T patent/ES2341174T3/es not_active Expired - Lifetime
- 2004-10-29 US US10/577,658 patent/US7718773B2/en not_active Expired - Fee Related
- 2004-10-29 CA CA2543935A patent/CA2543935C/fr not_active Expired - Fee Related
- 2004-10-29 DE DE602004025265T patent/DE602004025265D1/de not_active Expired - Lifetime
- 2004-10-29 CN CN2004800382227A patent/CN1898261B/zh not_active Expired - Fee Related
- 2004-10-29 EP EP04805350A patent/EP1678204B1/de not_active Expired - Lifetime
- 2004-10-29 JP JP2006537368A patent/JP4728246B2/ja not_active Expired - Fee Related
-
2006
- 2006-04-30 IL IL175319A patent/IL175319A/en active IP Right Grant
Also Published As
| Publication number | Publication date |
|---|---|
| FR2861731A1 (fr) | 2005-05-06 |
| EP1678204B1 (de) | 2010-01-20 |
| DE602004025265D1 (de) | 2010-03-11 |
| FR2861731B1 (fr) | 2006-02-24 |
| JP2008502305A (ja) | 2008-01-31 |
| CN1898261B (zh) | 2011-08-17 |
| CA2543935A1 (fr) | 2005-05-12 |
| CA2543935C (fr) | 2014-12-02 |
| US20070196879A1 (en) | 2007-08-23 |
| IL175319A (en) | 2013-07-31 |
| US7718773B2 (en) | 2010-05-18 |
| CN1898261A (zh) | 2007-01-17 |
| EP1678204A1 (de) | 2006-07-12 |
| IL175319A0 (en) | 2006-09-05 |
| ES2341174T3 (es) | 2010-06-16 |
| JP4728246B2 (ja) | 2011-07-20 |
| WO2005042572A1 (fr) | 2005-05-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE455792T1 (de) | Neues phosphatbindendes protein, pharmazeutische zusammensetzungen, die dieses enthalten, und verwendung davon | |
| AU2003264419A1 (en) | Kdr peptides and vaccines containing the same | |
| IN2014CN02050A (de) | ||
| IN2015DN02553A (de) | ||
| AU2002305450A1 (en) | Proteomimetic compounds and methods | |
| MX348154B (es) | Anticuerpos de enlace a il-1-beta y fragmentos de los mismos. | |
| MX2008009493A (es) | Peptido novedoso y uso del mismo. | |
| ATE506957T1 (de) | Prophylaktisches/therapeutisches mittel für neurodegenerative erkrankungen | |
| DE602005020165D1 (de) | Verfahren zur herstellung von l-arginin, l-ornithin oder l-citrullin | |
| ATE495247T1 (de) | Chromoprotein und fluoroproteine | |
| ATE551353T1 (de) | Protein mit fusogener wirkung, nukleinsäuresequenzen, die für dieses protein codieren und pharmazeutische zusammensetzungen, die dieses enthalten | |
| WO2006028561A3 (en) | Novel purified fabi polypeptides from fransicella tularensis | |
| AU2003251728A1 (en) | Placental growth factor as a target for the treatment of osteoporosis | |
| WO2007013358A3 (en) | Vivit polypeptides, therapeutic agent comprising the same, and method of screening for anti-cancer agent | |
| WO2004013167A3 (en) | Purified polypeptides from enterococcus faecalis | |
| WO2004011638A3 (en) | Deoxyuridine 5' triphosphate nucleotidohydrolase polypeptides and structures | |
| PT1401871E (pt) | Moleculas de ligacao imunologicas que inibem a fusao sincicial de celulas do tropoblasto | |
| WO2009014160A1 (ja) | 膵癌の新規腫瘍マーカー | |
| WO2004058811A3 (en) | Crystal structures of yhhf polypeptides | |
| WO2003087352A3 (en) | Enolase polypeptides and structures | |
| DE60312497D1 (de) | Verwendung von protein maba (fabg1) aus mycobacterium tuberculosis zur herstellung und nachweis von antibiotika | |
| NZ603077A (en) | Biological materials and uses thereof | |
| WO2004042044A3 (en) | Crystal structures of bacterial guanylate kinases | |
| WO2004081165A3 (en) | Novel purified dihydrodipicolinate synthase polypeptides and structures thereof | |
| WO2004011491A3 (en) | Peptidyl-trna hydrolase of enterococcus faecalis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |